يعرض 1 - 10 نتائج من 29 نتيجة بحث عن '"Kopp, T. I."', وقت الاستعلام: 1.74s تنقيح النتائج
  1. 1

    المصدر: Delcoigne, B, Kopp, T I, Arkema, E, Hellgren, K, Provan, S A, Relas, H, Aaltonen, K, Trokovic, N, Gudbjornsson, B, Gröndal, G, Kristianslund, E, Dreyer, L & Askling, J 2022, ' EXPOSURE TO SPECIFIC TUMOR NECROSIS FACTOR INHIBITORS AND RISK OF DEMYELINATING AND INFLAMMATORY NEUROPATHY IN PATIENTS WITH INFLAMMATORY ARTHRITIS. A COLLABORATIVE OBSERVATIONAL STUDY ACROSS FIVE NORDIC RHEUMATOLOGY REGISTERS ', Annals of the Rheumatic Diseases, vol. 81, no. Suppl. 1, OP0060 , pp. 41 . https://doi.org/10.1136/annrheumdis-2022-eular.2866

  2. 2
    دورية أكاديمية
  3. 3

    المصدر: Helene Ibfelt, E, Kart Jacobsen, R, Kopp, T I, Cordtz, R, Svarre Jakobsen, A, Seersholm, N, Burhan Shaker, S & Dreyer, L 2020, ' Treatment with methotrexate and risk of lung disease in patients with rheumatoid arthritis : a nationwide population-based cohort study from Denmark ', Annals of the Rheumatic Diseases, vol. 79, no. Suppl. 1, OP0232 , pp. 147-148 . https://doi.org/10.1136/annrheumdis-2020-eular.1609

    مصطلحات موضوعية: musculoskeletal diseases

  4. 4
    دورية أكاديمية
  5. 5

    المصدر: Christensen, J R, Oturai, A B, Joensen, H, Kopp, T I, Kant, M, Rasmussen, P V, Sellebjerg, F, Sorensen, P S & Magyari, M 2019, ' Natalizumab usage in Denmark-report from the Danish National Multiple Sclerosis Registry ', Multiple Sclerosis Journal, vol. 25, no. 2 Suppl. 1, P608, pp. 291-292 . < https://doi.org/10.1177/1352458519868078 >

  6. 6

    المصدر: Sellebjerg, F, Rasmussen, P V, Frederiksen, J L, Nielsen, H H, Joensen, H, Kopp, T I, Sorensen, P S & Magyari, M 2019, ' A nationwide study of fingolimod for the treatment of multiple sclerosis ', Multiple Sclerosis Journal, bind 25, nr. 2 Suppl. 1, P986, s. 520-521 . https://doi.org/10.1177/1352458519868080

  7. 7
  8. 8
    دورية أكاديمية
  9. 9
    دورية أكاديمية
  10. 10
    دورية أكاديمية